Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DrugUtilisation: An R Package to Support Drug Utilisation Research Using the OMOP Common Data Model.

Pharmacoepidemiology and drug safety·2026
Same author

Systematic evaluation of medication adherence determinants across 137 active substances on population-level real-world health data.

Communications medicine·2026
Same author

Data Resource Profile: Linking nationwide health and social registries in Estonia (BIG-HEART).

International journal of epidemiology·2026
Same author

A Comprehensive Approach to Days' Supply Estimation in a Real-World Prescription Database: Algorithm Development and Validation Study.

Online journal of public health informatics·2026
Same author

The Estonian Biobank's journey from biobanking to personalized medicine.

Nature communications·2025
Same author

Using Synthetic Health Care Data to Leverage Large Language Models for Named Entity Recognition: Development and Validation Study.

Journal of medical Internet research·2025

Related Experiment Video

Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Extracting and Classifying Drug Discontinuations From Estonian Electronic Health Records: Development and Validation

Hendrik Šuvalov1, Nikita Umov2, Maria Malk1

  • 1Institute of Computer Science, University of Tartu, Tartu, Estonia.

Journal of Medical Internet Research
|June 17, 2026
PubMed
Summary

Large language models (LLMs) effectively extracted drug discontinuation reasons from Estonian clinical notes. LLMs show promise for analyzing unstructured data to improve medication adherence and patient safety.

Keywords:
EstonianLLMNLPclinical decision supportdata miningdrug adherencedrug discontinuationshealth care datalarge language modelnatural language processing

More Related Videos

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Related Experiment Videos

Last Updated: Jun 19, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Area of Science:

  • Pharmacovigilance
  • Health Informatics
  • Natural Language Processing

Background:

  • Medication adherence is critical for managing chronic diseases, but treatment discontinuation is common due to side effects, inefficacy, or cost.
  • Reasons for discontinuation are often buried in free-text clinical notes, hindering large-scale analysis.
  • Analyzing unstructured data in low-resource languages like Estonian presents unique challenges for traditional methods.

Purpose of the Study:

  • To evaluate the capability of large language models (LLMs) in extracting and classifying reasons for drug discontinuation from Estonian electronic health records.
  • To determine whether patients or clinicians initiated the discontinuation.
  • To characterize discontinuation patterns and initiators for statin and antidiabetic medications.

Main Methods:

  • Utilized prescription data and free-text anamneses from a 10% sample of the Estonian population (2012-2019).
  • Applied LLMs (Llama 3.1-70B and GPT-4o) to extract discontinuation phrases/reasons and classify them.
  • Assessed LLM performance on 100 randomly selected cases per drug group for extraction and classification accuracy.

Main Results:

  • Identified 625 antidiabetic drug and 233 statin discontinuation cases.
  • Achieved high precision (0.93-0.98) for phrase extraction and (0.95-0.96) for reason extraction.
  • Weighted F1-scores for reason classification ranged from 0.81-0.84, and for initiator classification from 0.64-0.78. Adverse reactions were the most frequent reason for statin (70%) and antidiabetic (44.8%) discontinuations.

Conclusions:

  • LLMs demonstrate strong accuracy in extracting and classifying medication discontinuation reasons in Estonian clinical narratives.
  • LLMs show variable but promising performance in identifying discontinuation initiators, enabling scalable analysis.
  • This approach unlocks valuable insights from unstructured clinical notes, aiding in monitoring treatment patterns and detecting adverse event signals.